Related Experiment Videos
The inborn errors of peroxisomal beta-oxidation: a review
R J Wanders1, C W van Roermund, R B Schutgens
1Department of Pediatrics, University Hospital Amsterdam, The Netherlands.
Journal of Inherited Metabolic Disease
|January 1, 1990
Summary
Inherited diseases impairing peroxisomal beta-oxidation are increasingly identified. Diagnosis involves analyzing very-long-chain fatty acids in plasma, with prenatal testing now available.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Growing recognition of inherited diseases affecting peroxisomal beta-oxidation.
- These disorders result from absent peroxisomes or specific enzyme deficiencies.
- Accumulation of very-long-chain fatty acids (VLCFAs) is a hallmark.
Purpose of the Study:
- To summarize current understanding of inherited disorders of peroxisomal beta-oxidation.
- To highlight diagnostic approaches and clinical features.
- To note advancements in prenatal diagnosis.
Main Methods:
- Biochemical diagnosis using gas-chromatographic analysis of plasma VLCFAs.
- Enzymic and immunological investigations to pinpoint specific defects.
- Review of clinical data and diagnostic advancements.
Main Results:
- Inborn errors of peroxisomal beta-oxidation lead to VLCFA accumulation.
- Patients often exhibit severe neurological abnormalities and early mortality.
- Prenatal diagnosis is now feasible for these conditions.
Conclusions:
- Peroxisomal beta-oxidation defects represent a significant group of inherited metabolic disorders.
- Accurate diagnosis relies on VLCFA analysis and further enzymatic/immunological studies.
- Early identification and prenatal diagnosis offer potential for improved management.